Antiviral Protein of Momordica charantia L. Inhibits Different Subtypes of Influenza A
Figure 3
Determination of the inhibitory effect of the protein of M. charantia against influenza virus A/PR/8/34 (H1N1) infected in MDCK cells. The twofold dilution of the pretreated protein of 1.4 to 0.175 mg/mL ((a)–(d), resp.) was used on the assay. The viral infected cell (e) and noninfected cell (f) were used as the positive and negative controls, respectively.
